BioNTech’s timeline has been out there for months — as DW was reminded in a snippy exchange in due diligence by email this Friday (10.9.2021). “We have communicated the timeline months ago,” wrote the press officer. And indeed, back in May, the German half of the BioNTech-Pfizer COVID-19 vaccine team announced it was aiming to submit applications for emergency use authorizations in the US and the European Union for children aged 2 to 5 years and those aged 5-11 years by September. Intentions are one thing, realities are another. But fortunately for BioNTech-Pfizer — the joint-effort vaccine now known as Comirnaty or just Pfizer — their …
